Vector Science and Therapeutics Corp.
PAIN.V
TSX
| 02/28/2026 | 11/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 13.70K | 309.20K | |||
| Gross Profit | -13.70K | -309.20K | |||
| SG&A Expenses | 290.70K | 470.90K | |||
| Depreciation & Amortization | 3.30K | 2.60K | |||
| Other Operating Expenses | -78.20K | -- | |||
| Total Operating Expenses | 229.40K | 782.80K | |||
| Operating Income | -229.40K | -782.80K | |||
| Income Before Tax | -241.10K | -987.80K | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -241.10K | -987.80K | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -241.10K | -987.80K | |||
| EBIT | -229.40K | -782.80K | |||
| EBITDA | -226.20K | -780.10K | |||
| EPS Basic | -0.02 | -0.09 | |||
| Normalized Basic EPS | -0.01 | -0.05 | |||
| EPS Diluted | -0.02 | -0.09 | |||
| Normalized Diluted EPS | -0.01 | -0.05 | |||
| Average Basic Shares Outstanding | 11.59M | 11.47M | |||
| Average Diluted Shares Outstanding | 11.59M | 11.47M | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||